Загрузка...
The Release of the Bromodomain Ligand N,N-Dimethylacetamide Adds Bioactivity to a Resorbable Guided Bone Regeneration Membrane in a Rabbit Calvarial Defect Model
N,N-Dimethylacetamide (DMA) is FDA approved as an excipient and is used as drug-delivery vehicle. Due to its amphipathic nature and diverse bioactivities, it appears to be a good combination of biodegradable poly-lactide-co-glycolide (PLGA)-based guided bone regeneration membranes. Here we show that...
Сохранить в:
| Опубликовано в: : | Materials (Basel) |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7040842/ https://ncbi.nlm.nih.gov/pubmed/31973011 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ma13030501 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|